The short version

Scott Galloway predicted on January 5, 2024: “Tech of the Year: GLP‑1 If 2023 was the year of GPT‑4, 2024 will be the year of GLP‑1. That is, Ozempic, Mounjaro, and all GLP‑1‑related weight loss technology.” Verdict: Called it. GLP-1 drugs saw explosive adoption and major impact on consumer behavior and industries, as predicted. While AI also remained prominent, the…

Prediction by

Scott Galloway

On January 5, 2024

“Tech of the Year: GLP‑1 If 2023 was the year of GPT‑4, 2024 will be the year of GLP‑1. That is, Ozempic, Mounjaro, and all GLP‑1‑related weight loss technology.”

Follow-up

GLP-1 drugs saw explosive adoption and major impact on consumer behavior and industries, as predicted. While AI also remained prominent, the significant impact of GLP-1 drugs in 2024 supports the \"year of GLP-1\" claim.

From the High Caliber AI network — see the AI for PR module in the course.